Abstract
The mechanism by which some types of cereal proteins trigger celiac disease (also known as gluten-sensitive enteropathy) is unknown. A strong candidate has now been put forward: a 33-amino-acid peptide that resists digestion. The peptide is susceptible to degradation by a bacterial enzyme, raising the possibility of a new therapeutic approach.